Overview

• Consolidated net profit for Q1 2025 rose 35.2% year-on-year to Rs 726.4 crore, supported by robust sales and operational efficiency.
• Revenue increased 29% to Rs 5,567 crore, while EBITDA grew 27.8% to Rs 1,264 crore, reflecting sustained business momentum.
• Sales volumes jumped 30.1% year-on-year to 312.4 million cases, with significant contributions from both organic growth in India and international markets.
• The board announced an interim dividend of Rs 0.50 per share, with the record date set for May 9, 2025.
• Strategic expansions, including new plants in Kangra and Prayagraj and ongoing South Africa integration, bolstered the company’s growth trajectory.